background image

Paid Clinical Trials Pennsylvania

Discover 3,056 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

for
Metastatic Castration-resistant Prostate Cancer
Location: 40 recruiting locations
Sponsor: Celgene

Sex: Male

Age: 18+

Code: NCT06764485

Phase3, Recruiting
Active & Responsive

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab

for
Relapsing Multiple Sclerosis (RMS)
Location: 61 recruiting locations
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06869785

Phase3, Recruiting
Active & Responsive

Project PEAK: Early Intervention for ADHD

for
Attention Deficit Hyperactivity Disorder,
Location: 1 recruiting location
Sponsor: Lehigh University

Sex: All

Age: 3 - 5

Code: NCT04627415

Recruiting
Active & Responsive

Pain Self-Management and Treatment Engagement for Patients Taking Opioids

for
Chronic Pain, Opioid Use Disorder, Opioid Misuse and Addiction
Location: 7 recruiting locations
Sponsor: University of Pittsburgh

Sex: All

Age: 18+

Code: NCT06855732

Recruiting
Active & Responsive

Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)

for
Tachycardia, Ventricular
Location: 10 recruiting locations
Sponsor: Varian, a Siemens Healthineers Company

Sex: All

Age: 18+

Code: NCT05765175

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Pembrolizumab/Lenvatinib With and Without Healthy Donor FMT (hdFMT) in Relapsed/ Refractory (R/R) Melanoma

for
PD-1 Refractory Advanced Melanoma
Location: 1 recruiting location
Sponsor: Diwakar Davar

Sex: All

Age: 18+

Code: NCT06030037

Phase2, Recruiting
Active & Responsive

Screening Study for Participants With Malignant Tumors

for
Solid Tumors
Location: 3 recruiting locations
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT05419375

Phase2, Recruiting
Active & Responsive

Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response

for
Primary Central Nervous System Lymphoma
Location: 5 recruiting locations
Sponsor: Providence Health & Services

Sex: All

Age: 18+

Code: NCT06175000

Phase2, Recruiting
Active & Responsive

Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme

for
Glioblastoma Multiforme
Location: 1 recruiting location
Sponsor: Global Neurosciences Institute

Sex: All

Age: 18+

Code: NCT02285959

Phase1, Recruiting
Active & Responsive

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

for
Propionic Acidemia
Location: 7 recruiting locations
Sponsor: ModernaTX, Inc.

Sex: All

Age: 1+

Code: NCT05130437

Phase1, Phase2, Recruiting

Popular cities in Pennsylvania

PittsburghAllentownPhiladelphiaHershey